HIGHLIGHTS
- who: Giuseppe Paolisso from the The Ohio State University, United States have published the paper: Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis, in the Journal: (JOURNAL)
SUMMARY
COPYRIGHT SGLT2 inhibitors have recently come to prominence in research due to their anti-atherosclerotic effect. The well-known beneficial effect of SGLT2 inhibitor administration on renal function could explain the highlighted data of a lower incidence of contrast medium side effects during revascularization procedures in acute myocardial infarction (AMI) patients. Molecular mechanisms for atherosclerosis Atherosclerosis is a vascular disorder characterized by lipid particles, immune . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.